United States Central Nervous System Disorders Therapeutics Market Report 2016

Publisher Name :
Date: 13-Oct-2016
No. of pages: 114
Inquire Before Buying

Notes:

Sales, means the sales volume of Central Nervous System Disorders Therapeutics

Revenue, means the sales value of Central Nervous System Disorders Therapeutics

This report studies sales (consumption) of Central Nervous System Disorders Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- GlaxoSmithKline

- Pfizer

- Eli Lilly

- Janssen Pharmaceuticals

- Novartis

- AB Science

- AbbVie

- Archer Pharmaceuticals

- F. Hoffmann-La Roche

- UCB

- SK Biopharmaceuticals

- Shire

- Sanofi

- Merck

- Mitsubishi Tanabe

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Central Nervous System Disorders Therapeutics in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Central Nervous System Disorders Therapeutics Market Report 2016

Table of Contents
United States Central Nervous System Disorders Therapeutics Market Report 2016
1 Central Nervous System Disorders Therapeutics Overview
1.1 Product Overview and Scope of Central Nervous System Disorders Therapeutics
1.2 Classification of Central Nervous System Disorders Therapeutics
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Central Nervous System Disorders Therapeutics
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Central Nervous System Disorders Therapeutics (2011-2021)
1.4.1 United States Central Nervous System Disorders Therapeutics Sales and Growth Rate (2011-2021)
1.4.2 United States Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2011-2021)
2 United States Central Nervous System Disorders Therapeutics Competition by Manufacturers
2.1 United States Central Nervous System Disorders Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Central Nervous System Disorders Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Central Nervous System Disorders Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Central Nervous System Disorders Therapeutics Market Competitive Situation and Trends
2.4.1 Central Nervous System Disorders Therapeutics Market Concentration Rate
2.4.2 Central Nervous System Disorders Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Central Nervous System Disorders Therapeutics Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Central Nervous System Disorders Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Central Nervous System Disorders Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Central Nervous System Disorders Therapeutics Price by Type (2011-2016)
3.4 United States Central Nervous System Disorders Therapeutics Sales Growth Rate by Type (2011-2016)
4 United States Central Nervous System Disorders Therapeutics Sales (Volume) by Application (2011-2016)
4.1 United States Central Nervous System Disorders Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Central Nervous System Disorders Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Central Nervous System Disorders Therapeutics Manufacturers Profiles/Analysis
5.1 GlaxoSmithKline
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Pfizer
5.2.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pfizer Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Eli Lilly
5.3.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Eli Lilly Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Janssen Pharmaceuticals
5.4.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Novartis
5.5.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Novartis Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 AB Science
5.6.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 AB Science Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 AbbVie
5.7.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 AbbVie Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Archer Pharmaceuticals
5.8.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Archer Pharmaceuticals Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 F. Hoffmann-La Roche
5.9.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 F. Hoffmann-La Roche Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 UCB
5.10.2 Central Nervous System Disorders Therapeutics Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 UCB Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 SK Biopharmaceuticals
5.12 Shire
5.13 Sanofi
5.14 Merck
5.15 Mitsubishi Tanabe
6 Central Nervous System Disorders Therapeutics Manufacturing Cost Analysis
6.1 Central Nervous System Disorders Therapeutics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Central Nervous System Disorders Therapeutics
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Central Nervous System Disorders Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Central Nervous System Disorders Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Central Nervous System Disorders Therapeutics Market Forecast (2016-2021)
10.1 United States Central Nervous System Disorders Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Central Nervous System Disorders Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Central Nervous System Disorders Therapeutics Sales Forecast by Application (2016-2021)
10.4 Central Nervous System Disorders Therapeutics Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Central Nervous System Disorders Therapeutics
Table Classification of Central Nervous System Disorders Therapeutics
Figure United States Sales Market Share of Central Nervous System Disorders Therapeutics by Type in 2015
Table Application of Central Nervous System Disorders Therapeutics
Figure United States Sales Market Share of Central Nervous System Disorders Therapeutics by Application in 2015
Figure United States Central Nervous System Disorders Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Central Nervous System Disorders Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Central Nervous System Disorders Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Central Nervous System Disorders Therapeutics Sales Share by Manufacturers
Figure 2016 Central Nervous System Disorders Therapeutics Sales Share by Manufacturers
Table United States Central Nervous System Disorders Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Central Nervous System Disorders Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Central Nervous System Disorders Therapeutics Revenue Share by Manufacturers
Table 2016 United States Central Nervous System Disorders Therapeutics Revenue Share by Manufacturers
Table United States Market Central Nervous System Disorders Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Central Nervous System Disorders Therapeutics Average Price of Key Manufacturers in 2015
Figure Central Nervous System Disorders Therapeutics Market Share of Top 3 Manufacturers
Figure Central Nervous System Disorders Therapeutics Market Share of Top 5 Manufacturers
Table United States Central Nervous System Disorders Therapeutics Sales by Type (2011-2016)
Table United States Central Nervous System Disorders Therapeutics Sales Share by Type (2011-2016)
Figure United States Central Nervous System Disorders Therapeutics Sales Market Share by Type in 2015
Table United States Central Nervous System Disorders Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Central Nervous System Disorders Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Central Nervous System Disorders Therapeutics by Type (2011-2016)
Table United States Central Nervous System Disorders Therapeutics Price by Type (2011-2016)
Figure United States Central Nervous System Disorders Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Central Nervous System Disorders Therapeutics Sales by Application (2011-2016)
Table United States Central Nervous System Disorders Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Central Nervous System Disorders Therapeutics Sales Market Share by Application in 2015
Table United States Central Nervous System Disorders Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Central Nervous System Disorders Therapeutics Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table AB Science Basic Information List
Table AB Science Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AB Science Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Archer Pharmaceuticals Basic Information List
Table Archer Pharmaceuticals Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Archer Pharmaceuticals Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table SK Biopharmaceuticals Basic Information List
Table SK Biopharmaceuticals Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table SK Biopharmaceuticals Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Basic Information List
Table Mitsubishi Tanabe Central Nervous System Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Central Nervous System Disorders Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Central Nervous System Disorders Therapeutics
Figure Manufacturing Process Analysis of Central Nervous System Disorders Therapeutics
Figure Central Nervous System Disorders Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Central Nervous System Disorders Therapeutics Major Manufacturers in 2015
Table Major Buyers of Central Nervous System Disorders Therapeutics
Table Distributors/Traders List
Figure United States Central Nervous System Disorders Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Central Nervous System Disorders Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Central Nervous System Disorders Therapeutics Production Forecast by Type (2016-2021)
Table United States Central Nervous System Disorders Therapeutics Consumption Forecast by Application (2016-2021)
  • Global Emollient Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 96
    This report studies the global Emollient market status and forecast, categorizes the global Emollient market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Emollient is the medical word for a moisturizer. Emollients trap moisture in the skin and form a Protective oily layer on the outer skin which helps skin repair and improves skin hy......
  • Global Liquid Biopsy Products Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 91
    This report studies the global Liquid Biopsy Products market status and forecast, categorizes the global Liquid Biopsy Products market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tum......
  • Global Squalane Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 94
    This report studies the global Squalane market status and forecast, categorizes the global Squalane market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa). Squalane is of a molecular formula C30H62 and has a specific stereochemical conformation. Squalane is traditionally sourced from ......
  • Global Microencapsulation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Microencapsulation is a process in which tiny particles or droplets are surrounded by a coating to give small capsules, of many useful properties. In general, it is used to incorporate food ingredients, enzymes, cells or other materials on a micro metric scale. Microencapsulation usually refers to sizes ranging from 1 µm to 1 mm. Scope of the Report: This report focuses on the Microencapsulation in global market, especially in North America, Europe and Asia-Pacific,......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Microencapsulation Market 2018, Forecast to 2023
    Published: 18-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Microencapsulation is a process in which tiny particles or droplets are surrounded by a coating to give small capsules, of many useful properties. In general, it is used to incorporate food ingredients, enzymes, cells or other materials on a micro metric scale. Microencapsulation usually refers to sizes ranging from 1 µm to 1 mm. Scope of the Report: This report focuses on the Microencapsulation in global market, especially in North America, Europe and Asia-Pacific,......
  • Global Halal Pharmaceuticals Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as 'haram' under the Shariah law. Scope of the Report: This report focuses on the Halal Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacif......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Halal Pharmaceuticals Market 2018, Forecast to 2023
    Published: 18-Jun-2018        Price: US 4880 Onwards        Pages: 135
    Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as 'haram' under the Shariah law. Scope of the Report: This report focuses on the Halal Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacif......
  • Global Physiological Saline Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Physiological Saline is a mixture of sodium chloride in water and has a number of uses in medicine. Applied to the affected area it is used to clean wounds, help remove contact lenses, and help with dry eyes. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection. Note: In this report, the unit should be bottle or bag, which depends on the package of the p......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Physiological Saline Market 2018, Forecast to 2023
    Published: 18-Jun-2018        Price: US 4880 Onwards        Pages: 131
    Physiological Saline is a mixture of sodium chloride in water and has a number of uses in medicine. Applied to the affected area it is used to clean wounds, help remove contact lenses, and help with dry eyes. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection. Note: In this report, the unit should be bottle or bag, which depends on the package of the p......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs